Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out'...

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• Integrin affinity regulation is crucial for tumor development, wound repair, and angiogenesis.
• Understanding alphavbeta3 integrin's molecular mechanisms is key to these processes.

Purpose of the Study:

• To characterize recombinant human alphavbeta3 (r-alphavbeta3) integrins.
• To compare the activation state of r-alphavbeta3 with native alphavbeta3 in cellular environments.
• To investigate the role of intracellular controls and cytoplasmic domains in alphavbeta3 affinity regulation.

Main Methods:

• Expression and purification of full-length and truncated r-alphavbeta3.
• Ligand specificity and selectivity assays using vitronectin, fibronectin, and fibrinogen.
• Comparison of recombinant and native alphavbeta3 on cell surfaces and in purified forms.
• Use of M21-L4 melanoma cells and M21-L-IIb cells expressing integrins.

Main Results:

• Purified r-alphavbeta3 exhibited high constitutive affinity for vitronectin, fibronectin, and fibrinogen.
• Cellular alphavbeta3 showed lower affinity, requiring Mn2+ activation for fibrinogen binding.
• Native alphavbeta3 and r-alphavbeta3 shared epitopes, cation requirements, and peptide susceptibility.
• Intracellular controls appear to reduce alphavbeta3 affinity in its cellular context.

Conclusions:

• Alphavbeta3 integrin affinity is actively regulated by intracellular mechanisms, contrasting with alphaIIbbeta3.
• Cytoplasmic domains of alphavbeta3 may serve as targets for negative regulators, modulating integrin activity.
• This finding has significant implications for understanding integrin function in physiological and pathological processes.